Flagship Ventures Fund V General Partner LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Flagship Ventures Fund V General Partner LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Flagship Ventures Fund V General Partner LLC. Flagship Ventures Fund V General Partner LLC is a 10% Owner in Evelo Biosciences, Inc. ($EVLO) and a Director in Kaleido Biosciences, Inc. ($KLDO) and a 10% Owner in Sana Biotechnology, Inc. ($SANA) and a 10% Owner in Foghorn Therapeutics Inc. ($FHTX) and a 10% Owner in Sigilon Therapeutics, Inc. ($SGTX).

Address: 55 CAMBRIDGE PARKWAY SUITE 800E CAMBRIDGE 02142 MA

Companies in which Flagship Ventures Fund V General Partner LLC is an Insider

Evelo Biosciences, Inc.

Trading Symbol: EVLO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Flagship Ventures Fund V General Partner LLC: 10% Owner
Holdings: 17,952,153 shares
Latest Transaction: May 15 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Foghorn Therapeutics Inc.

Trading Symbol: FHTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Flagship Ventures Fund V General Partner LLC: 10% Owner
Holdings: 4,054,054 shares
Latest Transaction: Oct 29 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Kaleido Biosciences, Inc.

Trading Symbol: KLDO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund V General Partner LLC: Director
Holdings: 1,545,852 shares
Latest Transaction: Mar 06 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sana Biotechnology, Inc.

Trading Symbol: SANA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund V General Partner LLC: 10% Owner
Holdings: 1,487,371 shares
Latest Transaction: Feb 10 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sigilon Therapeutics, Inc.

Trading Symbol: SGTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Flagship Ventures Fund V General Partner LLC: 10% Owner
Holdings: 8,888,888 shares
Latest Transaction: Dec 10 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Flagship Ventures Fund V General Partner LLC

Sentiment: All, EVLO, FHTX, KLDO, SANA, SGTX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 10 2021SANASana Biotechnology ...Flagship Ventures Fund V Gener ...10% OwnerOption ExerciseC0.0011,585,19900
Feb 10 2021SANASana Biotechnology ...Flagship Ventures Fund V Gener ...10% OwnerOption ExerciseC0.0011,441,32600
Feb 10 2021SANASana Biotechnology ...Flagship Ventures Fund V Gener ...10% OwnerOption ExerciseC0.009,725,12200
Feb 10 2021SANASana Biotechnology ...Flagship Ventures Fund V Gener ...10% OwnerOption ExerciseC0.001,487,37100
Feb 10 2021SANASana Biotechnology ...Flagship Ventures Fund V Gener ...10% OwnerBuyC0.0011,585,199011,585,1990 to 11.6 M
Feb 10 2021SANASana Biotechnology ...Flagship Ventures Fund V Gener ...10% OwnerBuyC0.0011,441,326011,441,3260 to 11.4 M
Feb 10 2021SANASana Biotechnology ...Flagship Ventures Fund V Gener ...10% OwnerBuyC0.009,725,12209,725,1220 to 9.7 M

View all Flagship Ventures Fund V General Partner LLC insider transactions.